Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Nov;42(5):645–650. doi: 10.1038/bjc.1980.297

Serum glycoprotein hormone alpha subunit, hormone receptors and disease stage in patients with breast cancer.

I A MacFarlane, D Barnes, J M Howat, R Swindell, P Durning, C G Beardwell, H Bush, R A Sellwood
PMCID: PMC2010551  PMID: 6161628

Abstract

The concentration of the common alpha subunit of the glycoprotein hormones was high in the serum of 21/56 (38%) of premenopausal patients and 22/106 (21%) of postmenopausal patients with primary breast cancer, at the time of presentation. 7/59 (12%) of patients with benign disease also had high alpha subunit levels. Tumour cytosol oestrogen and progesterone receptor status was determined in 80% of the patients with cancer, and there was a trend towards higher alpha levels in patients without receptors, but this was not statistically significant. In the premenopausal patients with cancer there was a significant correlation between alpha subunit level and disease stage, R = 0.47, P = 0.0001, but not in the postmenopausal patients. In view of the correlation with disease stage, high levels of alpha subunit in premenopausal patients with breast cancer at presentation with the primary tumour may indicate poor prognosis.

Full text

PDF
645

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Ribeiro G. G., Skinner L. G. Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. Eur J Cancer. 1977 Oct;13(10):1133–1143. doi: 10.1016/0014-2964(77)90012-3. [DOI] [PubMed] [Google Scholar]
  2. Barnes D. M., Skinner L. G., Ribeiro G. G. Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer? Br J Cancer. 1979 Dec;40(6):862–865. doi: 10.1038/bjc.1979.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19;294(8):405–410. doi: 10.1056/NEJM197602192940801. [DOI] [PubMed] [Google Scholar]
  4. Braunstein G. D., Forsythe A. B., Rasor J. L., Van Scoy-Mosher M. B., Thompson R. W., Wade M. E. Serum glycoprotein hormone alpha subunit levels in patients with cancer. Cancer. 1979 Nov;44(5):1644–1651. doi: 10.1002/1097-0142(197911)44:5<1644::aid-cncr2820440517>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  5. Cove D. H., Smith S. C., Walker R., Howell A. The synthesis of the glycoprotein hormone alpha subunit by human breast carcinomas. Eur J Cancer. 1979 May;15(5):693–702. doi: 10.1016/0014-2964(79)90143-9. [DOI] [PubMed] [Google Scholar]
  6. Dosogne-Guérin M., Stolarczyk A., Borkowski A. Prospective study of the alpha and beta subunits of human chorionic gonadotrophin in the blood of patients with various benign and malignant conditions. Eur J Cancer. 1978 May;14(5):525–532. doi: 10.1016/0014-2964(78)90255-4. [DOI] [PubMed] [Google Scholar]
  7. Hagen C., Gilby E. D., McNeilly A. S., Olgaard K., Bondy P. K., Rees L. H. Comparison of circulating glycoprotein hormones and their subunits in patients with oat cell carcinoma of the lung and uraemic patients on chronic dialysis. Acta Endocrinol (Copenh) 1976 Sep;83(1):26–35. doi: 10.1530/acta.0.0830026. [DOI] [PubMed] [Google Scholar]
  8. Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. doi: 10.1002/1097-0142(197908)44:2<671::aid-cncr2820440238>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  9. Kahn C. R., Rosen S. W., Weintraub B. D., Fajans S. S., Gorden P. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy. N Engl J Med. 1977 Sep 15;297(11):565–569. doi: 10.1056/NEJM197709152971101. [DOI] [PubMed] [Google Scholar]
  10. Kiang D. T., Frenning D. H., Goldman A. I., Ascensao V. F., Kennedy B. J. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med. 1978 Dec 14;299(24):1330–1334. doi: 10.1056/NEJM197812142992403. [DOI] [PubMed] [Google Scholar]
  11. Kourides I. A., Weintraub B. D., Ridgway E. C., Maloof F. Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab. 1975 May;40(5):872–885. doi: 10.1210/jcem-40-5-872. [DOI] [PubMed] [Google Scholar]
  12. Lippman M. E., Allegra J. C., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M., Aitken S. C., Warren R. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med. 1978 Jun 1;298(22):1223–1228. doi: 10.1056/NEJM197806012982203. [DOI] [PubMed] [Google Scholar]
  13. MacFarlane I. A., Robinson E. L., Bush H., Durning P., Howat J. M., Beardwell C. G., Shalet S. M. Thyroid function in patients with benign and malignant breast disease. Br J Cancer. 1980 Mar;41(3):478–480. doi: 10.1038/bjc.1980.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MacFarlane I. A., Thatcher N., Swindell R., Beardwell C. G., Hayward E., Crowther D. Serum glycoprotein hormone alpha sub-unit values and survival in metastatic melanoma patients. Eur J Cancer. 1979 Dec;15(12):1497–1501. doi: 10.1016/0014-2964(79)90030-6. [DOI] [PubMed] [Google Scholar]
  15. Macfarlane I. A., Beardwell C. G., Shalet S. M., Darbyshire P. J., Hayward E., Sutton M. L. Glycoprotein hormone alpha subunit secretion by pituitary adenomas: influence of external irradiation. Clin Endocrinol (Oxf) 1980 Sep;13(3):215–222. doi: 10.1111/j.1365-2265.1980.tb01045.x. [DOI] [PubMed] [Google Scholar]
  16. Rosemberg E., Bulat G. Immunoreactive alpha and beta subunits of follicle stimulating and luteinizing hormones in peripheral blood throughout the menstrual cycle and following stimulation with synthetic gonadotropin releasing hormone (GnRH). J Endocrinol Invest. 1979 Jul-Sep;2(3):233–239. doi: 10.1007/BF03350408. [DOI] [PubMed] [Google Scholar]
  17. Say C. C., Donegan W. L. Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer. 1974 Aug;34(2):468–471. doi: 10.1002/1097-0142(197408)34:2<468::aid-cncr2820340235>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  18. Vaitukaitis J. L., Ross G. T., Braunstein G. D., Rayford P. L. Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res. 1976;32:289–331. doi: 10.1016/b978-0-12-571132-6.50019-1. [DOI] [PubMed] [Google Scholar]
  19. Walker R. A. Significance of alpha-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique. J Clin Pathol. 1978 Mar;31(3):245–249. doi: 10.1136/jcp.31.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES